Big Gain For ADC Therapeutics SA

Wed, Dec 13, 2023 at 07:30 PM

ADC Therapeutics SA (ADCT:NYSE) shot up at $1.68, a gain of 63.1%. On Wed, Dec 13, 2023, ADCT:NYSE touched a New 2-Week High of $1.68. The stock got featured on our News Catalysts scanner on Tue, Dec 12, 2023 at 08:42 AM in the 'MERGER' category. From Wed, Nov 29, 2023, the stock recorded 50.00% Up Days and 72.73% Green Days

About ADC Therapeutics SA (ADCT:NYSE)

ADC Therapeutics SA is a United States-based clinical-stage oncology-focused biotechnology company.

Top 10 Gainers:

Kubient Inc. (KBNT:NASDAQ), 280.77%
C4 Therapeutics Inc. (CCCC:NASDAQ), 135.47%
Shattuck Labs Inc. (STTK:NASDAQ), 130.33%
Signature Bank (SBNY:NASDAQ), 96.72%
Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
Avalo Therapeutics Inc. (AVTX:NASDAQ), 70.03%
NextPlay Technologies Inc. (NXTP:NASDAQ), 68.87%
LQR House Inc. (LQR:NASDAQ), 65.89%
View Inc. (VIEW:NASDAQ), 65.15%
ADC Therapeutics SA (ADCT:NYSE), 63.11%